Loading your page…

Pharmaceutical group

KITE

11 medicines6 countries

A group of 2 companies with 11 medicines in 6 countries.

Its medicines

Group structure

2 companies in 1 country

Netherlands1

Kite Pharma Eu B.V.Authorisation holder · 8 medicines

Headquarters not stated1

Kite Pharma, Inc.Authorisation holder · 3 medicines · listed in Saudi Arabia, United States

Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.

Medicines

Every medicine of every company in the group, current ones first.

11 medicines

Medicine	Substance	Country	Status	Authorised
TECARTUSDispersione per infusione	Brexucabtagene autoleucel	Italy	Authorised
Tecartus	Brexucabtagene autoleucel	EU (EMA)	Authorised	2020
Tecartus210^6 CAR-positive viable T cells per kg body weight · For Injection	Brexucabtagene autoleucel	United States	Marketed	2020
Tecartus 0.4-2.0 x 10^8 cellen, dispersie voor infusieOplossing voor infusie	Brexucabtagene autoleucel	Netherlands	Authorised	2020
TECARTUS 0,4 - 2 x 10e8 CELULAS DISPERSION PARA PERFUSION1 × 10e6 a 2 x 10e6 CELULAS · Dispersion para perfusion	Brexucabtagene autoleucel	Spain	Marketed	2020
Yescarta2 10^6 car-positive viable t cells per kg of body weight · Injection	Axicabtagene ciloleucel	United States	Marketed	2017
Yescarta	Axicabtagene ciloleucel	EU (EMA)	Authorised	2018
YESCARTADispersione per infusione	Axicabtagene ciloleucel	Italy	Authorised
YESCARTA 0,4 - 2 x 10e8 CELULAS DISPERSION PARA PERFUSION2 x 10e8 CELULAS · Dispersion para perfusion	Axicabtagene ciloleucel	Spain	Marketed	2018
Yescarta, maximum of 2 x 108 cells/68 ml dispersie voor infusieOplossing voor infusie	Axicabtagene ciloleucel	Netherlands	Authorised	2018
Yescarta	Axicabtagene ciloleucel	Saudi Arabia	Authorised

Sources and licences

Country	Medicines	Current	Companies
Spain	2	2	Companies All medicines
European Union (EMA)	2	2	Companies All medicines
Italy	2	2	Companies All medicines
Netherlands	2	2	Companies All medicines
United States	2	2	Companies All medicines
Saudi Arabia	1	1	Companies All medicines

Compiled by Prognia from the public medicine and company registers below. Logos are not used.

Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.

European Medicines Agency

Source: European Medicines Agency (EPAR data).

Licence: EMA reuse policy (source acknowledgement required)

Agencia Española de Medicamentos y Productos Sanitarios (CIMA)

Fuente de la información: AEMPS (CIMA).

Licence: AEMPS open data reuse with attribution

Base de données publique des médicaments (ANSM, HAS, UNCAM)

Source: BDPM (ANSM, HAS, UNCAM).

Licence: Licence Ouverte v1.0

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required

BDPM / ANSM, HAS and UNCAM

BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained

Licence: BDPM exact Licence Ouverte v1.0 (October 2011)

All 11 sources

Agenzia Italiana del Farmaco (AIFA), Italy

Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.

Licence: CC BY 4.0; AIFA published open-data catalog

Agenzia Italiana del Farmaco (AIFA), Italy

Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.

Licence: CC BY 4.0; AIFA published open-data catalog

College ter Beoordeling van Geneesmiddelen

College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.

Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim

Saudi Food and Drug Authority

Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.

Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only

U.S. Food and Drug Administration

FDA Purple Book, September 2026 release; acquired 2026-10-10T15:29:54.330165+00:00; exact source fields retained with source-key projections.

Licence: FDA-created structured factual administrative metadata; public-domain policy with third-party exceptions

Report an error or request removalCorrections from the company itself are welcome.

KITE

Group structure

Netherlands1

Headquarters not stated1

Medicines

Know your medicines, with the sources.

KITE

Group structure

Netherlands1

Headquarters not stated1

Medicines

Know your medicines, with the sources.

Countries

Therapeutic areas

Top substances

Names in the registers

Sources and licences

At a glance

Other big groups

Group structure

🇳🇱Netherlands1

Headquarters not stated1

Medicines

Know your medicines, with the sources.

Group structure

🇳🇱Netherlands1

Headquarters not stated1

Medicines

Know your medicines, with the sources.

Countries

Therapeutic areas

Top substances

Names in the registers

Sources and licences

At a glance

Netherlands1

Netherlands1